Smoking Cessation
📧 Sign up to get email alerts when something new happens for Smoking Cessation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study) [Phase 3]
A Phase 3 trial (CONVICT) evaluating whether combining nicotine replacement therapy with varenicline improves tobacco cessation outcomes has…
-
FDA approval · 2012-09-28FDA Approved: QUITINE NICOTINE — Supplemental Application (QUITINE LLC)
FDA approved a supplemental application for QUITINE NICOTINE (nicotine polacrilex) from Quitine LLC.
-
FDA approval · 2012-09-28FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex) from Strategic Sourcing Services LLC.
-
FDA approval · 2012-09-18FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Nicorette (nicotine polacrilex) by Haleon US Holdings LLC. The approval updates the product's re…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Motivation and Nicotine Patch Treatment for Under-served Smokers [NA]
A completed clinical trial from The Miriam Hospital investigates nicotine patch treatment for under-served smokers in smoking cessation. The…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3 [NA]
A completed clinical trial evaluating the effects of nicotine patch use in male and female smokers. The study examined outcomes related to n…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy [NA]
An update on the efficacy and safety results of a novel nicotine replacement therapy for smoking cessation from a completed trial.
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets
Post-marketing surveillance study assessing the safety and efficacy of Champix (varenicline) tablets for smoking cessation; the study is com…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation [Phase 3]
A second Phase 3 study of the NicVAX vaccine versus placebo as an aid for smoking cessation has completed.
-
FDA approval · 2012-04-25FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex) submitted by Strategic Sourcing Services LLC.
-
FDA approval · 2012-04-19FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Nicotine (nicotine polacrilex) by Wal-Mart Stores Inc, for this nicotine replacement ther…
-
FDA approval · 2012-03-27FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for bupropion hydrochloride from Apnar Pharma LP, granting approval for a generic product under an A…
-
FDA approval · 2011-12-15FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Nicotine (nicotine polacrilex) submitted by Wal-Mart Stores Inc.
-
FDA approval · 2011-12-06FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Nicorette (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2011-10-31FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Nicotine (nicotine polacrilex) submitted by Wal-Mart Stores Inc.
-
FDA approval · 2011-09-27FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
The FDA approved a supplemental application for NICORETTE 4MG FRUIT CHILL GUM from Lil' Drug Store Products, Inc., confirming continued regu…
-
FDA approval · 2011-09-12FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC. The action relates to nico…
-
FDA approval · 2011-07-22FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Chantix (varenicline tartrate) from Pfizer Laboratories Div Pfizer Inc., indicating an updat…
-
EMA safety_alert · 2011-07-21European Medicines Agency confirms positive benefit-risk balance for Champix
The EMA confirms a positive benefit-risk balance for Champix (varenicline) following ongoing safety assessments, indicating continued approv…
-
FDA approval · 2011-07-20FDA Approved: EQUATE NICOTINE — Original Application (Wal-Mart Stores Inc)
FDA approved Wal-Mart's Equate Nicotine, a generic nicotine polacrilex lozenge, under an original application (ANDA) for smoking cessation.
-
FDA approval · 2011-07-20FDA Approved: BASIC CARE NICOTINE — Original Application (Amazon.com Services LLC)
FDA approved Basic Care Nicotine (nicotine polacrilex) under an Original Application (ANDA) from Amazon.com Services LLC, adding a store-bra…
-
FDA approval · 2011-06-29FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for CHANTIX (varenicline tartrate) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2011-02-17FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for CHANTIX (varenicline tartrate) submitted by Pfizer Laboratories Div Pfizer Inc, updating the…
-
FDA approval · 2010-12-17FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved Pfizer's supplemental application for CHANTIX (varenicline tartrate).
-
FDA approval · 2010-08-27FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrylex) by Haleon US Holdings LLC.